Showing results (1-10 of 88) with videos related to
Sort By:
Pageof 9
Cancer Research Communications|June 5, 2024
Cancer-related Fatigue and the Additive Effect of Treatment in the Context of Lymphoma: An Analysis of the Lymphoma Coalition's 2022 Global Patient SurveySteve E Kalloger, Amanda Watson, Shawn Sajkowski, et al.International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|June 23, 2010
High-grade endometrial carcinoma: serous and grade 3 endometrioid carcinomas have different immunophenotypes and outcomesAbdulmohsen Alkushi, Martin Köbel, Steve E Kalloger, et al.Journal of Cancer Survivorship : Research and Practice|September 30, 2022
Mapping the experiences of people with advanced cancer across multiple cancer types-a scoping reviewSteve E Kalloger, Cheryl Ho, Craig Mitton, et al.Journal of Obstetrics and Gynaecology Canada : JOGC = Journal D'Obstetrique Et Gynecologie Du Canada : JOGC|September 16, 2014
Determinants of quality of life in ovarian cancer survivors: a pilot studyFlora F Teng, Steve E Kalloger, Lori Brotto, et al.Biomarker Insights|October 18, 2021
Advancing the Care of Pancreatic Cancer Patients: Moving Beyond Just Tumour TissueSteve E Kalloger, Joanna M Karasinska, Cassia Warren, et al.Gynecologic Oncology|January 1, 2008
The prognostic significance of elongation factor eEF1A2 in ovarian cancerDixie E Pinke, Steve E Kalloger, Tanja Francetic, et al.International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|May 31, 2011
Biomarker expression in pelvic high-grade serous carcinoma: comparison of ovarian and omental sitesMartin Köbel, Dmitry Turbin, Steve E Kalloger, et al.International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|September 28, 2013
Stage II to IV low-grade serous carcinoma of the ovary is associated with a poor prognosis: a clinicopathologic study of 32 patients from a population-based tumor registryRola H Ali, Steve E Kalloger, Jennifer L Santos, et al.Gynecologic Oncology|October 14, 2009
Tumor type and substage predict survival in stage I and II ovarian carcinoma: insights and implicationsMartin Köbel, Steve E Kalloger, Jennifer L Santos, et al.International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|February 23, 2010
Primary ovarian mucinous carcinoma of intestinal type: significance of pattern of invasion and immunohistochemical expression profile in a series of 31 casesAli Dastranj Tabrizi, Steve E Kalloger, Martin Köbel, et al.Pageof 9